• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有大血管病变的糖尿病患者的红细胞滤过性和代谢状态。

Red cell filterability and metabolic state in diabetic subjects with macro-angiopathy.

作者信息

Le Devehat C, Lemoine A, Cirette B, Ramet M

出版信息

Scand J Clin Lab Invest Suppl. 1981;156:155-8. doi: 10.3109/00365518109097450.

DOI:10.3109/00365518109097450
PMID:6948378
Abstract

In twenty control subjects, twenty diabetic patients without macro-angiopathy and forty diabetic patients with an acute and severe arteriopathy of lower limbs, we studied the red cell filterability (TFE) on total blood, the 2-3 diphosphoglycerate level (2-3 DPG) and the Adenosine Triphosphate level (ATP). The diabetic's impairement of the red cell filterability and ATP level are all the more important than the subject is suffering from an acute arteriopathy of lower limbs. For the same subjects, we notice that the 2-3 DPG level increases significantly. The filterability is related to the ATP red cell concentration. An ATP depletion produces an increase membrane rigidity and a minor filterability. These findings strongly suggest a relation that can exist between the red cell metabolic state and filterability in diabetic population with or without macroangiopathy.

摘要

在20名对照受试者、20名无大血管病变的糖尿病患者和40名患有急性严重下肢动脉病变的糖尿病患者中,我们研究了全血的红细胞滤过率(TFE)、2,3-二磷酸甘油酸水平(2,3-DPG)和三磷酸腺苷水平(ATP)。糖尿病患者红细胞滤过率和ATP水平的损害比患有急性下肢动脉病变的受试者更为严重。对于相同的受试者,我们注意到2,3-DPG水平显著升高。滤过率与红细胞ATP浓度相关。ATP耗竭会导致膜刚性增加和滤过率降低。这些发现强烈表明,在有或无大血管病变的糖尿病患者中,红细胞代谢状态与滤过率之间可能存在关联。

相似文献

1
Red cell filterability and metabolic state in diabetic subjects with macro-angiopathy.患有大血管病变的糖尿病患者的红细胞滤过性和代谢状态。
Scand J Clin Lab Invest Suppl. 1981;156:155-8. doi: 10.3109/00365518109097450.
2
Pharmacological influences of pentoxifylline on red cell filterability and 2-3 diphosphoglycerate.
Scand J Clin Lab Invest Suppl. 1981;156:301-3. doi: 10.3109/00365518109097497.
3
[Assessment of the 2,3-diphosphoglycerate content of erythrocytes in diabetes mellitus].[糖尿病患者红细胞2,3 - 二磷酸甘油酸含量的评估]
Probl Endokrinol (Mosk). 1982 Sep-Oct;28(5):15-7.
4
Red cell filterability in diabetes.糖尿病患者的红细胞滤过性
Scand J Clin Lab Invest Suppl. 1981;156:171-3. doi: 10.3109/00365518109097453.
5
Postoperative and glucose-induced hypophosphatemia in relation to adenosine triphosphate and 2,3-diphosphoglycerate in erythrocytes.术后及葡萄糖诱导的低磷血症与红细胞中三磷酸腺苷和2,3-二磷酸甘油酸的关系
Acta Chir Scand. 1989 Feb;155(2):81-7.
6
Red cell 2, 3-diphosphoglycerate levels among diabetic patents with and without vascular complications.有和没有血管并发症的糖尿病患者的红细胞2,3-二磷酸甘油酸水平
Diabetes. 1975 Aug;24(8):724-9. doi: 10.2337/diab.24.8.724.
7
Erythrocyte adenosine triphosphate depletion during voluntary hyperventilation.自主过度通气期间红细胞三磷酸腺苷耗竭
J Appl Physiol (1985). 1985 Oct;59(4):1196-200. doi: 10.1152/jappl.1985.59.4.1196.
8
Filterability and vascular disease--I. Red cell filterability in diabetes mellitus: its relation to other methods of measuring deformability and to blood viscosity.滤过性与血管疾病——I. 糖尿病患者的红细胞滤过性:其与其他测量变形性方法及血液粘度的关系
Scand J Clin Lab Invest Suppl. 1981;156:151-4. doi: 10.3109/00365518109097449.
9
[Erythrocytic 2-3-diphosphoglycerate in diabetes mellitus].[糖尿病中的红细胞2,3-二磷酸甘油酸]
Minerva Med. 1980 Jun 16;71(24):1731-4.
10
Evaluation of adenosine triphosphate and 2,3-diphosphoglycerate after twenty-four hours in red cells washed for neonatal transfusion.对用于新生儿输血的洗涤红细胞二十四小时后的三磷酸腺苷和2,3-二磷酸甘油酸的评估。
Vox Sang. 1988;54(2):71-3. doi: 10.1111/j.1423-0410.1988.tb01619.x.

引用本文的文献

1
Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM.尼索地平可改善红细胞变形性受损的情况,这与非胰岛素依赖型糖尿病患者细胞内游离钙离子浓度升高及血糖控制不佳相关。
Br J Clin Pharmacol. 1999 May;47(5):499-506. doi: 10.1046/j.1365-2125.1999.00934.x.